D-0921-2017 Class II Terminated
Recall Details
- Product Type
- Drugs
- Report Date
- June 28, 2017
- Initiation Date
- June 1, 2017
- Termination Date
- September 25, 2019
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- a) 44168 bottles; b) 24960 bottles
Product Description
Venlafaxine Hydrochloride Extended-Release Capsules USP, 75 mg, packaged in a) 30-count bottles (NDC 52343-132-30) and b) 90-count bottles (NDC 52343-132-90), Rx only, Distributed by: Lucid Pharma LLC, 2 Tower Center Blvd, Suite-1101-B, East Brunswick, NJ 08816 USA.
Reason for Recall
Failed Tablet/Capsules Specifications: pharmacists complaints for bottles containing melted capsules.
Distribution Pattern
Nationwide in the USA
Code Information
Lot #: a) V17516045-A, Exp 08/18; b) V17516047-A 09/18